OUR PUBLICATIONS

Radiopharmaceutical Therapy Provides Superior Survival Advantage for Leptomeningeal Metastasis Compared to External Beam Radiotherapy

Preclinical Evaluation of [{{{177}}}Lu]Lu-ART-101 for Radiopharmaceutical Therapy of Advanced Prostate Cancer

Priming Versus Propagating: Distinct Immune Effects of Alpha- Versus Beta-Particle Emitting Radiopharmaceuticals When Combined with Immune Checkpoint Inhibition in Mice

Low-Dose Radiation by Radiopharmaceutical Therapy Enhances GD2 TRAC-CAR T Cell Efficacy in Localized Neuroblastoma

Immunomodulatory Effects of Alpha vs Beta Radiopharmaceutical Therapy in Murine Prostate Cancer

Radiation to All Macroscopic Sites of Tumor Permits Greater Systemic Antitumor Response to In Situ Vaccination

Profound immunomodulatory effects of 225Ac-NM600 drive enhanced anti-tumor response in prostate cancer

Antitumor efficacy of {{{90}}}Y-NM600 targeted radionuclide therapy and PD-1 blockade is limited by regulatory T cells in murine prostate tumors

Next-Generation Cancer Magnetic Resonance Imaging With Tumor-Targeted Alkylphosphocholine Metal Analogs

Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion dog) setting

Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade

Optimizing Flow Cytometric Analysis of Immune Cells in Samples Requiring Cryopreservation from Tumor-Bearing Mice

Low-Dose Radiation Potentiates the Propagation of Anti-Tumor Immunity against Melanoma Tumor in the Brain after In Situ Vaccination at a Tumor outside the Brain

Temporal analysis of type 1 interferon activation in tumor cells following external beam radiotherapy or targeted radionuclide therapy

{{{177}}}Lu-NM600 Targeted Radionuclide Therapy Extends Survival in Syngeneic Murine Models of Triple-Negative Breast Cancer6

Preclinical Characterization of {{{86/90}}}Y-NM600 in a Variety of Murine and Human Cancer Tumor Models

In Silico Docking of Alkylphosphocholine Analogs to Human Serum Albumin Predict Partitioning and Pharmacokinetics

{{{90}}}Y-NM600 targeted radionuclide therapy induces immunologic memory in syngeneic models of T-cell Non-Hodgkin’s Lymphoma